Last reviewed · How we verify
Salbutamol sulphate 6 mg — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Salbutamol sulphate 6 mg (Salbutamol sulphate 6 mg) — Boehringer Ingelheim.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Salbutamol sulphate 6 mg TARGET | Salbutamol sulphate 6 mg | Boehringer Ingelheim | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Salbutamol sulphate 6 mg CI watch — RSS
- Salbutamol sulphate 6 mg CI watch — Atom
- Salbutamol sulphate 6 mg CI watch — JSON
- Salbutamol sulphate 6 mg alone — RSS
Cite this brief
Drug Landscape (2026). Salbutamol sulphate 6 mg — Competitive Intelligence Brief. https://druglandscape.com/ci/salbutamol-sulphate-6-mg. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab